DECAL Regimen

Known as: DECAL, Dexamethasone-Etoposide-Cisplatin-Cytarabine-L'asparaginase Regimen 
A regimen consisting of dexamethasone, etoposide, cytarabine and L-asparaginase, used for the treatment of recurrent childhood Non-Hodgkin lymphoma.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2008
0119782008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The survival mechanism of dormant tubercle bacilli is unknown; however, accumulating evidence indicates that Mycobacterium… (More)
Is this relevant?
2002
2002
Despite prolonged therapy (18 months), children with advanced non-lymphoblastic, non-Hodgkin's lymphoma (NHL) treated on previous… (More)
  • table 1
  • table 2
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2001
2001
PURPOSE To determine the toxicity and response rate in children treated with dexamethasone, etoposide, cisplatin, high-dose… (More)
Is this relevant?
2000
2000
We describe the use of a method called differential expression using customized amplification library (DECAL) to study the global… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Understanding the effects of the external environment on bacterial gene expression can provide valuable insights into an array of… (More)
Is this relevant?
1978
1978
This paper describes the development and the application o f the Design Communication Algorithm (DECAL) which is currently being… (More)
  • figure 3
Is this relevant?